Metagenomi (MGX) Non-Current Deffered Revenue (2023 - 2025)
Historic Non-Current Deffered Revenue for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $1.9 million.
- Metagenomi's Non-Current Deffered Revenue fell 8474.78% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 8474.78%. This contributed to the annual value of $10.2 million for FY2024, which is 6689.84% down from last year.
- Per Metagenomi's latest filing, its Non-Current Deffered Revenue stood at $1.9 million for Q3 2025, which was down 8474.78% from $3.6 million recorded in Q2 2025.
- Metagenomi's 5-year Non-Current Deffered Revenue high stood at $30.9 million for Q4 2023, and its period low was $1.9 million during Q3 2025.
- Moreover, its 3-year median value for Non-Current Deffered Revenue was $11.3 million (2024), whereas its average is $12.6 million.
- In the last 5 years, Metagenomi's Non-Current Deffered Revenue crashed by 6689.84% in 2024 and then tumbled by 8474.78% in 2025.
- Quarter analysis of 3 years shows Metagenomi's Non-Current Deffered Revenue stood at $30.9 million in 2023, then plummeted by 66.9% to $10.2 million in 2024, then crashed by 81.48% to $1.9 million in 2025.
- Its Non-Current Deffered Revenue stands at $1.9 million for Q3 2025, versus $3.6 million for Q2 2025 and $4.4 million for Q1 2025.